Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines

por Uziel, O, Fenig, E, Nordenberg, J, Beery, E, Reshef, H, Sandbank, J, Birenbaum, M, Bakhanashvili, M, Yerushalmi, R, Luria, D, Lahav, M
Publicado 2005

Differential downregulation of telomerase activity by bortezomib in multiple myeloma cells-multiple regulatory pathways in vitro and ex vivo

por Weiss, C, Uziel, O, Wolach, O, Nordenberg, J, Beery, E, Bulvick, S, Kanfer, G, Cohen, O, Ram, R, Bakhanashvili, M, Magen-Nativ, H, Shilo, N, Lahav, M
Publicado 2012